Medical Stocks To Watch Now – February 10th

Eli Lilly and Company, Merck & Co., Inc., Thermo Fisher Scientific, Tempus AI, and Onsemi are the five Medical stocks to watch today, according to MarketBeat’s stock screener tool. Medical stocks refer to shares of companies that operate within the healthcare sector, including pharmaceutical, biotechnology, medical device, and healthcare services companies. These stocks are typically traded on financial markets and can be influenced by factors such as regulatory approvals, clinical trial results, and overall market conditions. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of LLY stock traded down $17.61 during trading hours on Monday, reaching $860.70. The company had a trading volume of 1,496,490 shares, compared to its average volume of 3,912,757. The business has a fifty day moving average price of $789.87 and a 200-day moving average price of $843.19. Eli Lilly and Company has a one year low of $711.40 and a one year high of $972.53. The firm has a market cap of $817.08 billion, a PE ratio of 73.46, a price-to-earnings-growth ratio of 1.87 and a beta of 0.42. The company has a debt-to-equity ratio of 2.03, a quick ratio of 0.97 and a current ratio of 1.27.

Read Our Latest Research Report on LLY

Merck & Co., Inc. (MRK)

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products.

Shares of MRK stock traded down $0.57 during trading hours on Monday, reaching $86.71. The company had a trading volume of 11,146,700 shares, compared to its average volume of 13,528,705. The business has a fifty day moving average price of $98.72 and a 200-day moving average price of $106.34. Merck & Co., Inc. has a one year low of $86.85 and a one year high of $134.63. The firm has a market cap of $219.36 billion, a PE ratio of 12.90, a price-to-earnings-growth ratio of 0.83 and a beta of 0.38. The company has a debt-to-equity ratio of 0.79, a quick ratio of 1.15 and a current ratio of 1.36.

Read Our Latest Research Report on MRK

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

NYSE TMO traded down $19.54 during trading hours on Monday, hitting $551.94. 1,577,696 shares of the company’s stock traded hands, compared to its average volume of 2,050,139. The company has a current ratio of 1.66, a quick ratio of 1.29 and a debt-to-equity ratio of 0.59. Thermo Fisher Scientific has a 52 week low of $493.30 and a 52 week high of $627.88. The firm has a market capitalization of $211.12 billion, a P/E ratio of 33.40, a P/E/G ratio of 3.18 and a beta of 0.77. The business’s fifty day moving average price is $547.34 and its two-hundred day moving average price is $572.24.

Read Our Latest Research Report on TMO

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

NASDAQ:TEM traded up $0.92 during trading hours on Monday, hitting $69.88. 12,455,790 shares of the stock traded hands, compared to its average volume of 11,775,631. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. Tempus AI has a 1 year low of $22.89 and a 1 year high of $79.49. The stock has a 50 day moving average price of $44.49 and a 200 day moving average price of $49.16.

Read Our Latest Research Report on TEM

Onsemi (ON)

onsemi is engaged in disruptive innovations and also a supplier of power and analog semiconductors. The firm offers vehicle electrification and safety, sustainable energy grids, industrial automation, and 5G and cloud infrastructure, with a focus on automotive and industrial end-markets. It operates through the following segments: Power Solutions Group, Advanced Solutions Group, and Intelligent Sensing Group.

Shares of ON stock traded down $3.61 during mid-day trading on Monday, hitting $47.64. The company had a trading volume of 14,239,419 shares, compared to its average volume of 9,121,344. Onsemi has a 52-week low of $46.57 and a 52-week high of $85.16. The stock’s 50 day moving average price is $60.60 and its 200-day moving average price is $67.49. The company has a debt-to-equity ratio of 0.30, a current ratio of 3.07 and a quick ratio of 2.02. The company has a market capitalization of $20.29 billion, a P/E ratio of 11.84, a P/E/G ratio of 10.27 and a beta of 1.61.

Read Our Latest Research Report on ON

Featured Stories